Mycoplasma hyopneumoniae vaccine
US9120859B2 · kind B2 · utility
9Cited by
45References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2013 |
| Grant date | Sep 1, 2015 |
| Priority date | — |
| Expiry date | Mar 26, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2770/10034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides an immunogenic composition including a soluble portion of a Mycoplasma hyopneumoniae (M.hyo) whole cell preparation, wherein the soluble portion of the M.hyo preparation is substantially free of both (i) IgG and (ii) immunocomplexes comprised of antigen bound to immunoglobulin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.